secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001688757-22-000098
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs Q3 revenue $38.2M (+31.7% YoY); tightens 2022 guidance to $158-162M
--------------------------------------------------------------------------------

- Q3 revenue $38.2M, up 31.7% YoY (37.7% constant currency); net loss $10.5M vs $9.0M in Q3 2021.
- Gross margin improved to 68.1% from 67.6%; operating expenses rose 27.5% to $36.6M.
- 2022 revenue guidance tightened to $158-162M from $155-165M; constant-currency growth 30-33% YoY.
- Cash balance $65.3M as of Sep 30; expects Mia Femtech launch and China approval in 1H 2023.
- Plans to submit Motiva Implants for U.S. FDA approval in Q4 2022; all U.S. IDE trial cohorts enrolled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875722000098/0001688757-22-000098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875722000098/esta-20221107.htm
  HTML page:      https://secwatch.observer/filing/0001688757-22-000098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer